165 related articles for article (PubMed ID: 11729370)
1. Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction.
Halkin A; Roth A; Jonas M; Behar S
J Thromb Thrombolysis; 2001 Oct; 12(2):177-84. PubMed ID: 11729370
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.
Garratt KN; Brady PA; Hassinger NL; Grill DE; Terzic A; Holmes DR
J Am Coll Cardiol; 1999 Jan; 33(1):119-24. PubMed ID: 9935017
[TBL] [Abstract][Full Text] [Related]
3. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
[TBL] [Abstract][Full Text] [Related]
4. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
[TBL] [Abstract][Full Text] [Related]
5. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.
Zeller M; Danchin N; Simon D; Vahanian A; Lorgis L; Cottin Y; Berland J; Gueret P; Wyart P; Deturck R; Tabone X; Machecourt J; Leclercq F; Drouet E; Mulak G; Bataille V; Cambou JP; Ferrieres J; Simon T;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4993-5002. PubMed ID: 20702526
[TBL] [Abstract][Full Text] [Related]
6. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes.
Hasdai D; Granger CB; Srivatsa SS; Criger DA; Ellis SG; Califf RM; Topol EJ; Holmes DR
J Am Coll Cardiol; 2000 May; 35(6):1502-12. PubMed ID: 10807453
[TBL] [Abstract][Full Text] [Related]
8. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
[TBL] [Abstract][Full Text] [Related]
9. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
Malmberg K; Norhammar A; Wedel H; Rydén L
Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.
Harjai KJ; Stone GW; Boura J; Mattos L; Chandra H; Cox D; Grines L; O'Neill W; Grines C;
Am J Cardiol; 2003 May; 91(9):1041-5. PubMed ID: 12714143
[TBL] [Abstract][Full Text] [Related]
12. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Shindler DM; Palmeri ST; Antonelli TA; Sleeper LA; Boland J; Cocke TP; Hochman JS
J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1097-103. PubMed ID: 10985711
[TBL] [Abstract][Full Text] [Related]
15. Predicting clinical outcome in diabetics vs. non diabetics with acute myocardial infarction after thrombolysis, using ECG as a tool.
Khan MA; Khawaja MN; Hakeem F
J Pak Med Assoc; 2011 Oct; 61(10):1032-7. PubMed ID: 22356049
[TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project).
Berger AK; Breall JA; Gersh BJ; Johnson AE; Oetgen WJ; Marciniak TA; Schulman KA
Am J Cardiol; 2001 Feb; 87(3):272-7. PubMed ID: 11165959
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics.
Huizar JF; Gonzalez LA; Alderman J; Smith HS
J Am Coll Cardiol; 2003 Sep; 42(6):1017-21. PubMed ID: 13678923
[TBL] [Abstract][Full Text] [Related]
18. Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.
Arruda-Olson AM; Patch RK; Leibson CL; Vella A; Frye RL; Weston SA; Killian JM; Roger VL
Mayo Clin Proc; 2009; 84(1):28-33. PubMed ID: 19121251
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
[TBL] [Abstract][Full Text] [Related]
20. Asessement of myocardial infarction therapy development in diabetics.
Polewczyk A; Janion M; Gasior M; Gierlotka M; Poloński L
Pol Arch Med Wewn; 2008 Sep; 118(9):470-7. PubMed ID: 18846981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
